Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 81 - 90 of 120 results for "Biotech"

Market Wrap - Midday

AAP  |  MONDAY, 18 APR 2011
... the healthcare sector over the last few years, people have taken it as a safe haven," Ms Cox said. Pharmaceutical and biotech company CSL Ltd was up 45 cents at $35.35 by 1210 AEST. At 1213 AEST, the price of spot gold in Sydney was $US1485.78, up $US9.98 ...

Market Wrap - Midday

AAP  |  FRIDAY, 1 APR 2011
The Australian stock market was more than half a per cent higher at noon as speculation re-emerged that Shell could sell its stake in Woodside to BHP. At 1200 AEDT, the benchmark S&P/ASX200 index was 28.4 points higher, or 0.59 per cent, at 4,866.3 ...

Market wrap

AAP  |  THURSDAY, 17 FEB 2011
The Australian market is receiving clear, positive leads from offshore trading overnight, with all three key Wall Street indices substantially higher, as were European and Asian markets. Gold was flat but higher, oil was higher, but silver and copper ...

Bell Potter faces $22m class action

ELISE BURGESS  |  FRIDAY, 3 DEC 2010
... The class action, held in the Federal Court of Australia, alleges that Bell Potter encouraged clients to buy shares in biotech company, Progen Pharmaceuticals (PGL) in 2007. Shortly after, Bell Potter was appointed as co-underwriter of a capital raising ...

ASIC bans adviser and charges former director

ELISE BURGESS  |  WEDNESDAY, 10 NOV 2010
... separate charges after allegedly raising funds from nine investors through Financial Partners, Venture Capital Management and Biotech Solutions before allegedly depositing the money into bank accounts he controlled, using the funds for the three companies ...

Market Wrap - Morning

AAP  |  THURSDAY, 7 OCT 2010
... Treasury notes. In company news, WPG Resources Ltd executive chairman Bob Duffin will address a Sydney Mining Club luncheon. Biotech company Broadvector Ltd is scheduled to list on the Australian Stock Exchange. On Wednesday, Australian stocks touched ...

Temasek invests $50m in renewable fuels

MICHAEL HOBBS  |  THURSDAY, 8 APR 2010
Singapore sovereign wealth fund (SWF), Temasek Holdings, has invested $50 million in Californian-based renewable chemicals and fuel start-up company, Amyris Biotechnologies. The company will use the funds to support commercial plant design and construction ...

Platinum snubs US healthcare reforms

MICHAEL HOBBS  |  FRIDAY, 26 MAR 2010
... they have underpins their valuation." Rather, the investment team is targeting companies that attract business from Asia. Biotech stocks remain a focus. "We see biotech companies as the engine for these big pharmaceuticals firms so we've kept them even ...

Wingate appoints senior analyst

COMPANY RELEASE  |  TUESDAY, 24 NOV 2009
International equities manager Wingate Asset Management has appointed former Royal Bank of Scotland executive Alastair MacLeod as senior investment analyst. MacLeod joins Wingate from Royal Bank of Scotland in New York where he held roles including ...

Super funds back biotech fund

MICHAEL HOBBS  |  FRIDAY, 7 NOV 2008
Victorian Funds Management Corporation (VFMC), ARIA and Meat Industry Employees' Superannuation Fund are investing in the GBS Venture Partners BioVentures IV fund, which closed with more than $100 million in commitments. Macquarie Group, Quay Partners ...